Firefly Neuroscience (AIFF) Other Non-Current Assets (2010 - 2026)
Firefly Neuroscience (AIFF) posted Other Non-Current Assets of $352000.0 for Q2 2026, up 38.58% on a QoQ basis from $254000.0 in Q1 2026, and down 64.8% year-over-year from $1.0 million in Q2 2025.
Analysis
Firefly Neuroscience (AIFF) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Firefly Neuroscience has reported Other Non-Current Assets for 16 years, with the latest figure at $352000.0 in Q2 2026.
- On a quarterly basis, Other Non-Current Assets fell 64.8% year-over-year to $352000.0 in Q2 2026; TTM through Jun 2026 was $352000.0, a 64.8% decrease from a year earlier, with the FY2025 full-year figure at $268000.0, down 83.83% from the prior year.
- Other Non-Current Assets was $352000.0 for Q2 2026 at Firefly Neuroscience, up from $254000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $1.7 million in Q1 2025, with the low at $18419.0 in Q1 2024.
- Average Other Non-Current Assets over 5 years is $459835.2, with a median of $79305.0 recorded in 2022.
- The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets jumped 9031.87% in 2025, then plunged 84.9% in 2026.
- Over 5 years, Other Non-Current Assets stood at $79305.0 in 2022, then sank by 74.0% to $20623.0 in 2023, then soared by 7934.72% to $1.7 million in 2024, then tumbled by 83.83% to $268000.0 in 2025, then jumped by 31.34% to $352000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $352000.0 (Q2 2026), $254000.0 (Q1 2026), and $268000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 2.25 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 59.72 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | 6.62 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 2.41 Bn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 5.71 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | 165.90 Mn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 3.42 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 37.70 Mn |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | 352,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 352,000.00 |
| Mar 31, 2026 | 254,000.00 |
| Dec 31, 2025 | 268,000.00 |
| Sep 30, 2025 | 669,000.00 |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 18,419.00 |
| Mar 31, 2024 | 18,419.00 |
| Sep 30, 2023 | 20,623.00 |
| Jun 30, 2023 | 20,623.00 |
| Mar 31, 2023 | 79,305.00 |
| Dec 31, 2022 | 79,305.00 |
| Sep 30, 2022 | 79,305.00 |
| Jun 30, 2022 | 77,100.00 |
| Mar 31, 2022 | 77,100.00 |
| Dec 31, 2021 | 77,100.00 |
| Sep 30, 2021 | 5,707.00 |
| Jun 30, 2021 | 5,706.00 |